Cargando…
Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma
Melanoma is a severe and life-threatening malignancy derived from melanocytes. The traditional treatment for melanoma could not sustain satisfactory outcomes long term; however, the recent immune checkpoint treatment has made a breakthrough in these problems. Nivolumab is a representative immune che...
Autores principales: | Saito, Ryuichi, Sawada, Yu, Nakamura, Motonobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920420/ https://www.ncbi.nlm.nih.gov/pubmed/33669410 http://dx.doi.org/10.3390/ijms22041957 |
Ejemplares similares
-
Tattoo-like Spread of Malignant Melanoma
por: Mashima, Emi, et al.
Publicado: (2018) -
Daily Lifestyle and Cutaneous Malignancies
por: Sawada, Yu, et al.
Publicado: (2021) -
T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
por: Sparger, Ellen E., et al.
Publicado: (2021) -
The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies
por: Sawada, Yu, et al.
Publicado: (2020) -
Nivolumab in the treatment of malignant melanoma: review of the literature
por: Mashima, Emi, et al.
Publicado: (2015)